메뉴 건너뛰기




Volumn 45, Issue 1, 2014, Pages 302-310

The role of Src family kinases in growth and migration of glioma stem cells

Author keywords

CD133; Dasatinib; Glioblastoma; Glioma stem cells; Migration; Src family kinases

Indexed keywords

CD133 ANTIGEN; DASATINIB; PROTEIN KINASE C SRC; PROTEIN KINASE FYN; PROTEIN KINASE LCK; PROTEIN KINASE YES; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; CSK TYROSINE-PROTEIN KINASE; FYN PROTEIN, HUMAN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE; THIAZOLE DERIVATIVE; YES1 PROTEIN, HUMAN;

EID: 84902592986     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2432     Document Type: Article
Times cited : (49)

References (41)
  • 1
    • 0034693877 scopus 로고    scopus 로고
    • Role of Src expression and activation in human cancer
    • Irby RB and Yeatman TJ: Role of Src expression and activation in human cancer. Oncogene 19: 5636-5642, 2000.
    • (2000) Oncogene , vol.19 , pp. 5636-5642
    • Irby, R.B.1    Yeatman, T.J.2
  • 2
    • 21344470873 scopus 로고    scopus 로고
    • Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells
    • Stettner MR, Wang W, Nabors LB, et al: Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells. Cancer Res 65: 5535-5543, 2005.
    • (2005) Cancer Res , vol.65 , pp. 5535-5543
    • Stettner, M.R.1    Wang, W.2    Nabors, L.B.3
  • 3
    • 0037105704 scopus 로고    scopus 로고
    • Promotion of malignant astrocytoma cell migration by osteopontin expressed in the normal brain: Differences in integrin signaling during cell adhesion to osteopontin versus vitronectin
    • Ding Q, Stewart J Jr, Prince CW, et al: Promotion of malignant astrocytoma cell migration by osteopontin expressed in the normal brain: differences in integrin signaling during cell adhesion to osteopontin versus vitronectin. Cancer Res 62: 5336-5343, 2002.
    • (2002) Cancer Res , vol.62 , pp. 5336-5343
    • Ding, Q.1    Stewart Jr., J.2    Prince, C.W.3
  • 4
    • 0038386613 scopus 로고    scopus 로고
    • Src family kinases in tumor progression and metastasis
    • Summy JM and Gallick GE: Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 22: 337-358, 2003.
    • (2003) Cancer Metastasis Rev , vol.22 , pp. 337-358
    • Summy, J.M.1    Gallick, G.E.2
  • 5
    • 0037150728 scopus 로고    scopus 로고
    • Src in cancer: Deregulation and consequences for cell behaviour
    • Frame MC: Src in cancer: deregulation and consequences for cell behaviour. Biochim Biophys Acta 1602: 114-130, 2003.
    • (2003) Biochim Biophys Acta , vol.1602 , pp. 114-130
    • Frame, M.C.1
  • 6
    • 16144364951 scopus 로고    scopus 로고
    • Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation
    • Yamaguchi H and Hendrickson WA: Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation. Nature 384: 484-489, 1996.
    • (1996) Nature , vol.384 , pp. 484-489
    • Yamaguchi, H.1    Hendrickson, W.A.2
  • 7
    • 75749103348 scopus 로고    scopus 로고
    • Src signaling in cancer invasion
    • Guarino M: Src signaling in cancer invasion. J Cell Physiol 223: 14-26, 2010.
    • (2010) J Cell Physiol , vol.223 , pp. 14-26
    • Guarino, M.1
  • 8
    • 70149112112 scopus 로고    scopus 로고
    • Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients
    • Lu KV, Zhu S, Cvrljevic A, et al: Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients. Cancer Res 69: 6889-6898, 2009.
    • (2009) Cancer Res , vol.69 , pp. 6889-6898
    • Lu, K.V.1    Zhu, S.2    Cvrljevic, A.3
  • 10
    • 33645072205 scopus 로고    scopus 로고
    • Treatment for advanced tumors: SRC reclaims center stage
    • Summy JM and Gallick GE: Treatment for advanced tumors: SRC reclaims center stage. Clin Cancer Res 12: 1398-1401, 2006.
    • (2006) Clin Cancer Res , vol.12 , pp. 1398-1401
    • Summy, J.M.1    Gallick, G.E.2
  • 11
    • 2942618768 scopus 로고    scopus 로고
    • A renaissance for SRC
    • Yeatman TJ: A renaissance for SRC. Nat Rev Cancer 4: 470-480, 2004.
    • (2004) Nat Rev Cancer , vol.4 , pp. 470-480
    • Yeatman, T.J.1
  • 12
    • 0019946972 scopus 로고
    • DNA sequence of the viral and cellular src gene of chickens. II. Comparison of the src genes of two strains of avian sarcoma virus and of the cellular homolog
    • Takeya T and Hanafusa H: DNA sequence of the viral and cellular src gene of chickens. II. Comparison of the src genes of two strains of avian sarcoma virus and of the cellular homolog. J Virol 44: 12-18, 1982.
    • (1982) J Virol , vol.44 , pp. 12-18
    • Takeya, T.1    Hanafusa, H.2
  • 13
    • 0023515851 scopus 로고
    • Cell transformation by the viral src oncogene
    • Jove R and Hanafusa H: Cell transformation by the viral src oncogene. Annu Rev Cell Biol 3: 31-56, 1987.
    • (1987) Annu Rev Cell Biol , vol.3 , pp. 31-56
    • Jove, R.1    Hanafusa, H.2
  • 14
    • 0030927381 scopus 로고    scopus 로고
    • Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice
    • Weissenberger J, Steinbach JP, Malin G, Spada S, Rulicke T and Aguzzi A: Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice. Oncogene 14: 2005-2013, 1997.
    • (1997) Oncogene , vol.14 , pp. 2005-2013
    • Weissenberger, J.1    Steinbach, J.P.2    Malin, G.3    Spada, S.4    Rulicke, T.5    Aguzzi, A.6
  • 15
    • 70350003803 scopus 로고    scopus 로고
    • Improving the prognosis for patients with glioblastoma: The rationale for targeting Src
    • de Groot J and Milano V: Improving the prognosis for patients with glioblastoma: the rationale for targeting Src. J Neurooncol 95: 151-163, 2009.
    • (2009) J Neurooncol , vol.95 , pp. 151-163
    • De Groot, J.1    Milano, V.2
  • 16
    • 40949099624 scopus 로고    scopus 로고
    • The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration
    • Dey N, Crosswell HE, De P, Parsons R, Peng Q, Su JD and Durden DL: The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration. Cancer Res 68: 1862-1871, 2008.
    • (2008) Cancer Res , vol.68 , pp. 1862-1871
    • Dey, N.1    Crosswell, H.E.2    De, P.3    Parsons, R.4    Peng, Q.5    Su, J.D.6    Durden, D.L.7
  • 17
    • 67651006461 scopus 로고    scopus 로고
    • Kinome profiling in pediatric brain tumors as a new approach for target discovery
    • Sikkema AH, Diks SH, den Dunnen WF, et al: Kinome profiling in pediatric brain tumors as a new approach for target discovery. Cancer Res 69: 5987-5995, 2009.
    • (2009) Cancer Res , vol.69 , pp. 5987-5995
    • Sikkema, A.H.1    Diks, S.H.2    Den Dunnen, W.F.3
  • 18
    • 60149089005 scopus 로고    scopus 로고
    • Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy
    • Du J, Bernasconi P, Clauser KR, et al: Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy. Nat Biotechnol 27: 77-83, 2009.
    • (2009) Nat Biotechnol , vol.27 , pp. 77-83
    • Du, J.1    Bernasconi, P.2    Clauser, K.R.3
  • 19
    • 38449123194 scopus 로고    scopus 로고
    • Src regulates phorbol 12-myristate 13-acetate-activated PKC-induced migration via Cas/Crk/Rac1 signaling pathway in glioblastoma cells
    • Nomura N, Nomura M, Sugiyama K and Hamada J: Src regulates phorbol 12-myristate 13-acetate-activated PKC-induced migration via Cas/Crk/Rac1 signaling pathway in glioblastoma cells. Int J Mol Med 20: 511-519, 2007.
    • (2007) Int J Mol Med , vol.20 , pp. 511-519
    • Nomura, N.1    Nomura, M.2    Sugiyama, K.3    Hamada, J.4
  • 20
    • 33845317573 scopus 로고    scopus 로고
    • Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
    • Bao S1, Wu Q, McLendon RE, et al: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760, 2006.
    • (2006) Nature , vol.444 , pp. 756-760
    • Bao, S.1    Wu, Q.2    McLendon, R.E.3
  • 21
    • 33845671339 scopus 로고    scopus 로고
    • + cancer stem cells in glioblastoma
    • + cancer stem cells in glioblastoma. Mol Cancer 5: 67, 2006.
    • (2006) Mol Cancer , vol.5 , pp. 67
    • Liu, G.1    Yuan, X.2    Zeng, Z.3
  • 23
    • 33751075186 scopus 로고    scopus 로고
    • ABC transporters, neural stem cells and neurogenesis - A different perspective
    • Lin T, Islam O and Heese K: ABC transporters, neural stem cells and neurogenesis - a different perspective. Cell Res 16: 857-871, 2006.
    • (2006) Cell Res , vol.16 , pp. 857-871
    • Lin, T.1    Islam, O.2    Heese, K.3
  • 24
    • 33749325184 scopus 로고    scopus 로고
    • Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen: High efficacy of drug combinations
    • Bradeen HA, Eide CA, O'Hare T, et al: Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen: high efficacy of drug combinations. Blood 108: 2332-2338, 2006.
    • (2006) Blood , vol.108 , pp. 2332-2338
    • Bradeen, H.A.1    Eide, C.A.2    O'Hare, T.3
  • 25
    • 60849137218 scopus 로고    scopus 로고
    • Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma
    • Milano V, Piao Y, LaFortune T and de Groot J: Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma. Mol Cancer Ther 8: 394-406, 2009.
    • (2009) Mol Cancer Ther , vol.8 , pp. 394-406
    • Milano, V.1    Piao, Y.2    LaFortune, T.3    De Groot, J.4
  • 26
    • 57649220776 scopus 로고    scopus 로고
    • An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours
    • Fael Al-Mayhani TM, Ball SL, Zhao JW, Fawcett J, Ichimura K, Collins PV and Watts C: An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours. J Neurosci Methods 176: 192-199, 2009.
    • (2009) J Neurosci Methods , vol.176 , pp. 192-199
    • Fael Al-Mayhani, T.M.1    Ball, S.L.2    Zhao, J.W.3    Fawcett, J.4    Ichimura, K.5    Collins, P.V.6    Watts, C.7
  • 27
    • 66049085403 scopus 로고    scopus 로고
    • Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens
    • Pollard SM, Yoshikawa K, Clarke ID, et al: Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 4: 568-580, 2009.
    • (2009) Cell Stem Cell , vol.4 , pp. 568-580
    • Pollard, S.M.1    Yoshikawa, K.2    Clarke, I.D.3
  • 28
    • 66149089157 scopus 로고    scopus 로고
    • The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases
    • Boivin D, Labbé D, Fontaine N, Lamy S, Beaulieu E, Gingras D and Béliveau R: The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases. Biochemistry 48: 3998-4007, 2009.
    • (2009) Biochemistry , vol.48 , pp. 3998-4007
    • Boivin, D.1    Labbé, D.2    Fontaine, N.3    Lamy, S.4    Beaulieu, E.5    Gingras, D.6    Béliveau, R.7
  • 29
    • 78649446893 scopus 로고    scopus 로고
    • Role of lymphocyte-specific protein tyrosine kinase (LCK) in the expansion of glioma-initiating cells by fractionated radiation
    • Kim RK, Yoon CH, Hyun KH, et al: Role of lymphocyte-specific protein tyrosine kinase (LCK) in the expansion of glioma-initiating cells by fractionated radiation. Biochem Biophys Res Commun 402: 631-636, 2010.
    • (2010) Biochem Biophys Res Commun , vol.402 , pp. 631-636
    • Kim, R.K.1    Yoon, C.H.2    Hyun, K.H.3
  • 30
    • 14744274624 scopus 로고    scopus 로고
    • Comparative analysis of two clinically active BCR-ABL kinase inhibitors reveals the role of conformation-specific binding in resistance
    • Burgess MR, Skaggs BJ, Shah NP, Lee FY and Sawyers CL: Comparative analysis of two clinically active BCR-ABL kinase inhibitors reveals the role of conformation-specific binding in resistance. Proc Natl Acad Sci USA 102: 3395-3400, 2005.
    • (2005) Proc Natl Acad Sci USA , vol.102 , pp. 3395-3400
    • Burgess, M.R.1    Skaggs, B.J.2    Shah, N.P.3    Lee, F.Y.4    Sawyers, C.L.5
  • 31
    • 19944428353 scopus 로고    scopus 로고
    • Discovery of N-(2-chloro-6-methyl-phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays
    • Lombardo LJ, Lee FY, Chen P, et al: Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino) thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. J Med Chem 47: 6658-6661, 2004.
    • (2004) J Med Chem , vol.47 , pp. 6658-6661
    • Lombardo, L.J.1    Lee, F.Y.2    Chen, P.3
  • 32
    • 3142676436 scopus 로고    scopus 로고
    • Overriding imatinib resistance with a novel ABL kinase inhibitor
    • Shah NP, Tran C, Lee FY, Chen P, Norris D and Sawyers CL: Overriding imatinib resistance with a novel ABL kinase inhibitor. Science 305: 399-401, 2004.
    • (2004) Science , vol.305 , pp. 399-401
    • Shah, N.P.1    Tran, C.2    Lee, F.Y.3    Chen, P.4    Norris, D.5    Sawyers, C.L.6
  • 33
    • 0026772431 scopus 로고
    • Platelet-derived growth factor and its receptors in human glioma tissue: Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops
    • Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B and Nistér M: Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52: 3213-3219, 1992.
    • (1992) Cancer Res , vol.52 , pp. 3213-3219
    • Hermanson, M.1    Funa, K.2    Hartman, M.3    Claesson-Welsh, L.4    Heldin, C.H.5    Westermark, B.6    Nistér, M.7
  • 34
    • 31144441457 scopus 로고    scopus 로고
    • Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: Possible implications for patient selection for imatinib mesylate therapy
    • Haberler C, Gelpi E, Marosi C, Rössler K, Birner P, Budka H and Hainfellner JA: Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy. J Neurooncol 76: 105-109, 2006.
    • (2006) J Neurooncol , vol.76 , pp. 105-109
    • Haberler, C.1    Gelpi, E.2    Marosi, C.3    Rössler, K.4    Birner, P.5    Budka, H.6    Hainfellner, J.A.7
  • 35
    • 38749092525 scopus 로고    scopus 로고
    • Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients
    • Wang LF, Fokas E, Bieker M, et al: Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients. Oncol Rep 19: 151-156, 2008.
    • (2008) Oncol Rep , vol.19 , pp. 151-156
    • Wang, L.F.1    Fokas, E.2    Bieker, M.3
  • 36
    • 27644466229 scopus 로고    scopus 로고
    • EphA2 as a novel molecular marker and target in glioblastoma multiforme
    • Wykosky J, Gibo DM, Stanton C and Debinski W: EphA2 as a novel molecular marker and target in glioblastoma multiforme. Mol Cancer Res 3: 541-551, 2005.
    • (2005) Mol Cancer Res , vol.3 , pp. 541-551
    • Wykosky, J.1    Gibo, D.M.2    Stanton, C.3    Debinski, W.4
  • 37
    • 51649111035 scopus 로고    scopus 로고
    • Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia
    • Porkka K, Koskenvesa P, Lundán T, et al: Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia. Blood 112: 1005-1012, 2008.
    • (2008) Blood , vol.112 , pp. 1005-1012
    • Porkka, K.1    Koskenvesa, P.2    Lundán, T.3
  • 38
    • 34648821254 scopus 로고    scopus 로고
    • Making a tumour's bed: Glioblastoma stem cells and the vascular niche
    • Gilbertson RJ and Rich JN: Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer 7: 733-736, 2007.
    • (2007) Nat Rev Cancer , vol.7 , pp. 733-736
    • Gilbertson, R.J.1    Rich, J.N.2
  • 39
    • 50849142558 scopus 로고    scopus 로고
    • Adult SVZ stem cells lie in a vascular niche: A quantitative analysis of niche cell-cell interactions
    • Shen Q, Wang Y, Kokovay E, et al: Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions. Cell Stem Cell 3: 289-300, 2008.
    • (2008) Cell Stem Cell , vol.3 , pp. 289-300
    • Shen, Q.1    Wang, Y.2    Kokovay, E.3
  • 40
    • 77956245743 scopus 로고    scopus 로고
    • Integrin alpha 6 regulates glioblastoma stem cells
    • Lathia JD, Gallagher J, Heddleston JM, et al: Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 6: 421-432, 2010.
    • (2010) Cell Stem Cell , vol.6 , pp. 421-432
    • Lathia, J.D.1    Gallagher, J.2    Heddleston, J.M.3
  • 41
    • 33646358694 scopus 로고    scopus 로고
    • Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines
    • Lee J, Kotliarova S, Kotliarov Y, et al: Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9: 391-403, 2006.
    • (2006) Cancer Cell , vol.9 , pp. 391-403
    • Lee, J.1    Kotliarova, S.2    Kotliarov, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.